Urinary phenylacetylglutamine appears to be a more useful marker than metabolite blood levels for therapeutic monitoring of phenylacetic acid (PAA) prodrugsM. Mokhtarani,G. A. Diaz,W. Rhead,U. Lichter-Konecki,J. Bartley,A. Feigenbaum,N. Longo, W. Berquist,S. A. Berry,R. Gallagher,D. Bartholomew,C. O. Harding,M. S. Korson,S. E. McCandless,W. Smith,J. Vockley,S. Bart,D. Kronn,R. Zori,Sandesh Sreenath-Nagamani, M. Summar,K. Dickinson,D. Coakley,B. Lee, B. F. ScharschmidtMOLECULAR GENETICS AND METABOLISM（2012）引用 0|浏览22暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
